CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - OSL:CONTX - SE0014731154 - Common Stock
4.76 NOK
-0.08 (-1.65%)
Overall CONTX gets a fundamental rating of 6 out of 10. We evaluated CONTX against 11 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making CONTX a very profitable company, without any liquidiy or solvency issues. CONTX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
CONTX had a positive operating cash flow in the past year.
Of the past 5 years CONTX 4 years were profitable.
CONTX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CONTX (10.31%) is better than 81.82% of its industry peers.
CONTX has a better Return On Equity (14.29%) than 72.73% of its industry peers.
CONTX's Return On Invested Capital of 12.59% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 9.34%.
The last Return On Invested Capital (12.59%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROIC | 12.59% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX's Profit Margin of 10.66% is fine compared to the rest of the industry. CONTX outperforms 63.64% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.82%, CONTX is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
CONTX's Operating Margin has improved in the last couple of years.
CONTX has a Gross Margin of 97.41%. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
CONTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
CONTX has a better Debt to FCF ratio (0.50) than 72.73% of its industry peers.
CONTX has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.08, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC6.97%
2.3 Liquidity
CONTX has a Current Ratio of 3.66. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.66, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 3.59 indicates that CONTX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.59, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
CONTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
Looking at the last year, CONTX shows a quite strong growth in Revenue. The Revenue has grown by 12.19% in the last year.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
3.2 Future
CONTX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.64% yearly.
Based on estimates for the next years, CONTX will show a decrease in Revenue. The Revenue will decrease by -0.20% on average per year.
EPS Next Y-28.88%
EPS Next 2Y-43.14%
EPS Next 3Y-26.79%
EPS Next 5Y-10.64%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-0.2%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CONTX is valuated reasonably with a Price/Earnings ratio of 10.58.
CONTX's Price/Earnings ratio is rather cheap when compared to the industry. CONTX is cheaper than 81.82% of the companies in the same industry.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.86), we can say CONTX is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for CONTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CONTX is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.07 | ||
| EV/EBITDA | 11.82 |
4.3 Compensation for Growth
CONTX has an outstanding profitability rating, which may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -26.79% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.14%
EPS Next 3Y-26.79%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 3.41, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.91% of the companies listed in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-43.14%
EPS Next 3Y-26.79%
OSL:CONTX (10/3/2025, 7:00:00 PM)
4.76
-0.08 (-1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap368.28M
Analysts40
Price Target5.1 (7.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-109.09%
EPS NY rev (3m)-104.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.39%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A | ||
| P/S | 2.84 | ||
| P/FCF | 18.07 | ||
| P/OCF | 13.3 | ||
| P/B | 3.81 | ||
| P/tB | 3.94 | ||
| EV/EBITDA | 11.82 |
EPS(TTM)0.45
EY9.45%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.26
FCFY5.53%
OCF(TTM)0.36
OCFY7.52%
SpS1.68
BVpS1.25
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROCE | 15.94% | ||
| ROIC | 12.59% | ||
| ROICexc | 44.69% | ||
| ROICexgc | 50.4% | ||
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% | ||
| FCFM | 15.71% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.84% | ||
| Profit Quality | 147.45% | ||
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z | N/A |
F-Score4
WACC6.97%
ROIC/WACC1.81
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-43.14%
EPS Next 3Y-26.79%
EPS Next 5Y-10.64%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-0.2%
EBIT growth 1Y-60.97%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-34.27%
OCF growth 3Y51.49%
OCF growth 5Y5.6%